Clonidin
PreclinicalSmall molecule
Clonidin is one of 8 small molecule programs targeting Stress. It is currently in Preclinical.
1
Indications
2
Total Trials
0
Active Trials
7
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
10 competitors in Stress
#DrugCompanyPhaseTrials
1Inderal
WWyeth-Lederle Vaccines
Approved
Psilocybin
COMPASS PathwaysPhase 2
Minipress
PfizerPreclinical
MS Contin
HHikma Pharmaceuticals LLC
Preclinical
Blood Collection
AAssistance Publique - Hôpitaux de Paris
Preclinical
Guanidine Hydrochloride
CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Preclinical
L-Tyrosine
DDirection Centrale du Service de Santé des Armées
Preclinical
Clonidin
MMedical University of Vienna
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Clonidin. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- MMedical University of Vienna